Cite
Wang S, Jiao F, Border JJ, et al. Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals. Am J Physiol Heart Circ Physiol. 2021;322(2):H246-H259doi: 10.1152/ajpheart.00438.2021.
Wang, S., Jiao, F., Border, J. J., Fang, X., Crumpler, R. F., Liu, Y., Zhang, H., Jefferson, J., Guo, Y., Elliott, P. S., Thomas, K. N., Strong, L. B., Urvina, A. H., Zheng, B., Rijal, A., Smith, S. V., Yu, H., Roman, R. J., & Fan, F. (2022). Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals. American journal of physiology. Heart and circulatory physiology, 322(2), H246-H259. https://doi.org/10.1152/ajpheart.00438.2021
Wang, Shaoxun, et al. "Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals." American journal of physiology. Heart and circulatory physiology vol. 322,2 (2022): H246-H259. doi: https://doi.org/10.1152/ajpheart.00438.2021
Wang S, Jiao F, Border JJ, Fang X, Crumpler RF, Liu Y, Zhang H, Jefferson J, Guo Y, Elliott PS, Thomas KN, Strong LB, Urvina AH, Zheng B, Rijal A, Smith SV, Yu H, Roman RJ, Fan F. Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals. Am J Physiol Heart Circ Physiol. 2022 Feb 01;322(2):H246-H259. doi: 10.1152/ajpheart.00438.2021. Epub 2021 Dec 24. PMID: 34951541.
Copy
Download .nbib